NSEInvestor Presentation4d ago · 3 Nov 2026, 02:58 pm

Investor Presentation

Bodal Chemicals Limited · BODALCHEM

✦ AI Summary▲ PositiveResults

Bodal Chemicals Limited has informed the Exchange about Investor Presentation, highlighting Q2 & H1FY27 financial performance with 67% revenue growth, 114% EBITDA growth, and 1259% net profit growth.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bodal Chemicals Limited has informed the Exchange about Investor Presentation

Attachments (1)

📄

BODALCHEM_03112026145812_Bodal_Chem_03_11_2026_Presentation.pdf

pdf

Download →
View document text
By Online Submission Sec/26-27/89 Date: 03-11-2026 To, The General Manager, The General Manager, National Stock Exchange of India Ltd. BSE Ltd. Exchange Plaza, 1st Floor, New Trading Ring, Plot no. C/1, G Block, Rotunda Building, P.J. Tower, Bandra-Kurla Complex Dalal Street, Fort Bandra (E), Mumbai - 400 051. Mumbai- 400 001 NSE CODE: BODALCHEM BSE Code: 524370 Dear Sir/Madam, SUB: Earning/Investor Presentation- November 2026 Ref: Regulation 30, Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With reference to the above captioned subject, we herewith enclosed Earning/Investor Presentation- November 2026 This is for your information and record please. Thanking You, For, BODAL CHEMICALS LTD. Ashutosh Bhatt Company Secretary Encl: As Above Bodal Chemicals Limited Investor Presentation-November 2026 Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Bodal Chemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. This presentation contains certain forward looking statements concerning the Company’s future business prospects and business profitability, which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals, time and cost over runs on contracts, our ability to manage our international operations, government policies and actions regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward looking statements become materially incorrect in future or update any forward looking statements made from time to time by or on behalf of the Company. Q2 & H1FY27 Highlights Business Highlights Revenue EBITDA PAT H1FY27 Rs 15,991 mn H1FY27 Rs. 2,027 mn H1FY27 Rs. 1,118 mn Q2FY27 Rs. 8,840 mn Q2FY27 Rs. 1,276 mn Q2FY27 Rs. 814 mn • During the H1FY27, Company achieved all time high total revenue of Rs 15,991 mn, 67% growth on YoY basis. This growth is led by better realization and improved volume across the divisions. The robust margin of key dyes intermediates and with effective pass through of higher raw material cost, the company has achieved highest absolute EBITDA of Rs. 2027 mn, remarkable 114% growth on YoY for the 1st half of current year. During Q2 Company achieved Total revenue at Rs. 8840 mn, 77 % growth on YoY basis. EBITDA stood at Rs.1276 mn, 197% growth on YoY basis with margin of 14%. Net Profit stood at Rs. 814 mn,1259% growth on YoY basis. • During the H1FY27, revenue from Dye intermediates grew by 68% led by volume with outstanding margin. Dyestuff grew by 42%, this improved realization helped to absorb raw material pressure and Basic Chemicals, grew by 136% YoY mainly due to increase in the prices of main raw material i.e. Sulphur. In Q2FY27, Revenue from Dye Intermediates stood at Rs.3,449 mn, grew by 88% quarterly on YoY basis, Revenue from Basic Chemicals Stood at Rs.990 mn, grew by 199% quarterly on YoY basis, Revenue from Dyestuffs stood at Rs.2,115 mn, grew by 60% quarterly on YoY basis. • During the H1FY27, revenue from Chlor Alkali business has grew by 6% on YoY basis, led by comparative better realization on YoY basis. In Q2FY27 Revenue from Chlor Alkali business stood at 908 mn, grew by 8% quarterly on YoY basis. • During the H1FY27, in Saykha’s the Benzene downstream products division has started contributing to the topline. Recent better realization and improved volume will lead to meaningful contribution on a quarter on quarter basis. • The Sener Boya- Turkish, Chinese and BCTPL subsidiaries have performed overall satisfactory during the Q2FY27. • Driven by an outstanding performance in our dyes intermediates division, higher volumes across the divisions, effective raw material cost pass-through, and integrated manufacturing capacity, we delivered record-high quarterly revenue and earnings. We anticipate that due to structural changes in China and stabilization of Benzene downstream products plant, better run should continue for the company in coming quarters. * On Consolidated basis 4 Performance Highlights Revenue (Rs. In Mn) EBITDA (Rs. In Mn) PAT (Rs. In Mn) 8.6% Q142.4F%Y26 1.2% 9.2% Margin 8,840 Q2 FY27 1,276 814 5,004 Performance Q2FY26 Q2FY27 Q2FY26 Q2FY27 Q2FY26 Q2FY27 9.9% 12.7% 1.6% 7.0% 15,991 H1FY27 2,027 1,118 Performance 9,586 H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27 * On Consolidated basis 5 Performance Highlights H1 FY26 H1 FY27 Revenue Rs 9,166 mn Revenue Rs 15,442 mn 9% 8% 12% 17% Basic Chemicals Dyestuff 18% Dye Intermediates Caustic Soda Others Domestc Export pukaerB euneveR pukaerB cihpargoeG * On Consolidated basis –Sales of products excluding other non operating income Performance Highlights Basic Chemicals Dyestuff Dye Intermediates Chlor Alkali^ 5,615 1,828 3,605 2,538 3,449 3,336 2,115 1,322 1,834 Q2’26 Q2’27 H1’26 H1’27 pukaerB euneveR emuloV noitcudorP (Rs in mn) 1,778 1,682 841 908 Q2’26 Q2’27 H1’26 H1’27 Q2’26 Q2’27 H1’26 H1’27 Q2’26 Q2’27 H1’26 H1’27 *Revenue breakup on a Consolidated basis (MT) 9056 16956 115248 113312 7834 14727 40889 38886 5314 58517 58343 4093 7835 8830 20332 20123 Q2’26 Q2’27 H1’26 H1’27 Q2’26 Q2’27 H1’26 H1’27 Q2’26 Q2’27 H1’26 H1’27 Q2’26 Q2’27 H1’26 H1’27 * Production Volume on a Standalone basis due to limited information on subsidiaries ^Production volume - Caustic Soda only Subsidiaries Performance (Rs in mn) BCTPL Sen-er Boya BCL China 165% -25% 27% 74 51 Q2FY26 Q2FY27 euneveR BCL Indonesia -62% Q2FY26 Q2FY27 Q2FY26 Q2FY27 Q2FY26 Q2FY27 Particulars BCTPL Sener Boya Bodal-China Bodal-Indonesia (Rs in mn) Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Sales 27.8 73.7 75.7 56.8 40.3 51.0 20.2 7.7 1.6 1.7 -11.9 4.6 9.5 4.4 5.2 -1.4 1.2 1.3 5.6 14.1 9.4 4.5 5.2 -1.4 Consolidated Profit & Loss Statement Particulars (Rs. In Mn) Q2 FY27 Q2 FY26 Y-o-Y% H1 FY27 H1 FY26 Y-o-Y% Revenue from Operation 8,633.7 4,804.5 15,724.2 9,346.6 Other Income 205.9 199.3 267.3 239.8 Total Revenue 8,839.6 5,003.8 76.7% 15,991.5 9,586.3 66.8% Raw Material Consumed 5,126.5 2,741.2 9,388.3 5,116.5 Employee Expenses 400.7 321.4 728.1 636.8 Other Expenses 2,023.9 1,493.2 3,822.3 2,854.0 Loss arising from Company's Subsidiary operating 12.7 18.9 25.8 33.3 in hyperinflationary economies EBITDA 1,275.9 429.1 197.3% 2,026.9 945.7 114.3% EBITDA (%) 14.4% 8.6% 12.7% 9.9% Depreciation 177.6 174.2 351.7 349.2 EBIT 1098.3 255.0 1675.2 596.5 EBIT (%) 12.4% 5.1% 10.5% 6.2% Finance Cost 198.3 199.2 384.0 415.5 Exceptional Items 0.0 0.3 0.0 0.3 Profit Before Tax 900.0 55.5 1,291.2 180.7 Tax 85.5 -4.4 172.9 25.5 Profit After Tax [Showing first 8,000 characters — download PDF for full document]